Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they ...
Pursuant to the terms of licensing agreement, MycoMedica will seek to develop EB-002, formerly EB-373, a synthetic prodrug of the active metabolite psilocin, in treatment of neuropsychiatric disorders ...
The study showed that unlike THC, CBN only weakly activates these receptors. To their surprise, the researchers found that a metabolite of CBN had significant effects on cannabinoid CB1 receptors. A ...